• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Induction of a protective immunity in mice against Escherichia coli by phenothiazines, 10-[n-(phthalimido)alkyl]-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazines-10-yl)alkyl-1 -ureas .

作者信息

Komatsu N, Motohashi N, Fujimaki M, Molnár J

机构信息

Public Welfare Institute of Scientific Research Foundation, Tokyo, Japan.

出版信息

In Vivo. 1997 Jan-Feb;11(1):13-6.

PMID:9067767
Abstract

Abilities of five phenothiazines, six 10-[n-(phthalimido)alkyl]-2-substituted-10H-phenothiazines and six 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazines-10-yl)alkyl-1- ureas to induce anti-Escherichia coli activity in mice were compared. Seventeen compounds tested in this study had no antibacterial effect in direct contact with Escherichia coli using the disk diffusion method except chlorpromazine (4) with low growth inhibitory action. The pretreatment of mice with several phenothiazines, 10-[n-(phthalimido)alkyl]-2-substituted-10H-phenothiazines or 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazines-10-yl)alkyl-1- ureas protected the animals from lethal infection of Escherichia coli to various extents. On the basis of these experiments, we assume that the protective effect against Escherichia coli infection might be due to the immunopotentiation or macrophage inducing activity by the compounds, or inactivation of lymphokines induced by the bacteria. Since the infection preventing effect of the tested phenothiazines depends on the chemical structures, the specificity of the biological process can be assumed.

摘要

相似文献

1
Induction of a protective immunity in mice against Escherichia coli by phenothiazines, 10-[n-(phthalimido)alkyl]-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazines-10-yl)alkyl-1 -ureas .
In Vivo. 1997 Jan-Feb;11(1):13-6.
2
Antitumor activity of phenothiazine-related compounds.吩噻嗪类相关化合物的抗肿瘤活性。
Anticancer Res. 1996 Jul-Aug;16(4A):1915-8.
3
Synthesis and antitumor activity of 1-[2-(chloroethyl)-3-(2-substituted-10H-phenothiazin-10-yl)alkyl- 1-urea s as potent anticancer agents.1-[2-(氯乙基)-3-(2-取代-10H-吩噻嗪-10-基)烷基]-1-脲作为强效抗癌剂的合成及其抗肿瘤活性
Anticancer Res. 1996 Sep-Oct;16(5A):2525-32.
4
Immunomodulating activities on cellular cytotoxicity and the blast transformation of human lymphocytes by 10-[n-(phthalimido)alkyl-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10 H-phenothiazin-10-yl)alkyl-1-ureas.
Anticancer Res. 1996 May-Jun;16(3A):1247-50.
5
Induction of anti-Escherichia coli activity in mice by phenothiazines, benzo[a]phenothiazines and benz[c]acridines.
In Vivo. 1992 Nov-Dec;6(6):585-8.
6
Induction of DNA fragmentation in human myelogenous leukaemic cell lines by phenothiazine-related compounds.吩噻嗪相关化合物对人骨髓性白血病细胞系DNA片段化的诱导作用。
Anticancer Res. 1995 Nov-Dec;15(6B):2533-40.
7
The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.“半芥子型”吩噻嗪类化合物在国立癌症研究所修订的抗癌筛选模式中的主要体外抗癌活性。
Anticancer Res. 1998 Jan-Feb;18(1A):337-48.
8
Antimicrobial activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines.吩噻嗪类、苯并[a]吩噻嗪类和苯并[c]吖啶类的抗菌活性。
Anticancer Res. 1992 Jul-Aug;12(4):1207-10.
9
Synthesis, spectral characterization, and biological activity of some new substituted 10H-phenothiazines, its ribofuranosides, and sulfones.一些新型取代的10H-吩噻嗪、其呋喃核糖苷和砜的合成、光谱表征及生物活性
Nucleosides Nucleotides Nucleic Acids. 2010 Mar;29(3):178-89. doi: 10.1080/15257771003708538.
10
Relationship between cytotoxic activity and dipole moment for phthalimido- and chloroethyl-phenothiazines.
Anticancer Res. 1999 Sep-Oct;19(5B):4081-3.